Mitsukazu Gotoh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mitsukazu Gotoh has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Koji Umeshita
Department of Surgery II, Osaka University Medical School, Department of Bioregulation, Biomedical Research Center, Osaka University, Osaka, Japan
6 shared publications- Masato Sakon
Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Osaka, Japan
5 shared publications - Akira Kenjo
Department of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University
4 shared publications - Keizo Dono
Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Osaka, Japan
4 shared publications - Morito Monden
Osaka University, Graduate School of Medicine
4 shared publications Takao Tsuchiya
Department of Regenerative Surgery, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan
4 shared publications
Latest Publications
- 4 April 2016
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 23 (5) , 298-304
Role of intratumoral infiltrating macrophages after transarterial immunoembolization for hepatocellular carcinoma
Background Preoperative transarterial immunoembolization (TIE) for hepatocellular carcinoma (HCC) is effective for preventing recurrence. We aimed to investigate the intratumoral and peritumoral M1 macrophage-induced immune response following TIE treatment. Methods We compared 13 patients treated with TIE between 2003 and 2009 (TIE group) and 13 patients treated with surgery alone during the same period of time at our institute (control group) using an immunohistological study with CD68 and CD163 antibodies. Results No significant differences in clinicopathological characteristics, except for surgical time, were observed between the two groups. The 3-year recurrence-free survival outcome of the TIE group was quite different from that of the control group (100% vs. 38.5%, P = 0.034). In the histological investigation, lytic necrosis and coagulation necrosis of the main tumor along with the presence of multinuclear giant cells were observed in 10 of the 13 patients in the TIE group. The immunohistological study showed that not only the numbers of intratumoral CD68+ cells, but also the numbers of intratumoral and peritumoral CD8+ cells were significantly increased in the TIE group. Conclusions The suppression of tumor recurrence induced by preoperative TIE might be induced by intratumoral M1 macrophages that are activated by OK-432 and fibrinogen.
- 4 April 2016
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 23 (5) , 298-304
Role of intratumoral infiltrating macrophages after transarterial immunoembolization for hepatocellular carcinoma
Background Preoperative transarterial immunoembolization (TIE) for hepatocellular carcinoma (HCC) is effective for preventing recurrence. We aimed to investigate the intratumoral and peritumoral M1 macrophage-induced immune response following TIE treatment. Methods We compared 13 patients treated with TIE between 2003 and 2009 (TIE group) and 13 patients treated with surgery alone during the same period of time at our institute (control group) using an immunohistological study with CD68 and CD163 antibodies. Results No significant differences in clinicopathological characteristics, except for surgical time, were observed between the two groups. The 3-year recurrence-free survival outcome of the TIE group was quite different from that of the control group (100% vs. 38.5%, P = 0.034). In the histological investigation, lytic necrosis and coagulation necrosis of the main tumor along with the presence of multinuclear giant cells were observed in 10 of the 13 patients in the TIE group. The immunohistological study showed that not only the numbers of intratumoral CD68+ cells, but also the numbers of intratumoral and peritumoral CD8+ cells were significantly increased in the TIE group. Conclusions The suppression of tumor recurrence induced by preoperative TIE might be induced by intratumoral M1 macrophages that are activated by OK-432 and fibrinogen.
- 1 November 2014
- Vol. 41 (12) , 2166-8
[A case of two re-resections for peritoneal recurrence of pancreatic cancer].
A 63-year-old man underwent subtotal stomach-preserving pancreaticoduodenectomy and intraoperative radiation therapy for pancreatic head cancer (Stage IVa, JPS). Subsequently, he received adjuvant chemotherapy including gemcitabine (GEM). A peritoneal recurrence appeared adjacent to the right colon and the lower pole of the right kidney. He received chemotherapy including S-1 and GEM+S-1. Since the recurrent lesions were localized, he underwent resection for the recurrence lesions 2 years and 9 months after surgery. The resection was R1, and re-recurrence appeared in the lower pole of the right kidney. After chemotherapy and chemoradiotherapy, he underwent re-resection for the recurrence 4 years and 3 months after the first surgery. Three months after re-resection, multiple liver metastases appeared in the bilateral lobes. Reoperation can be one of the multidisciplinary management options for local recurrence of pancreatic cancer under specific conditions.
- 1 November 2014
- Vol. 41 (12) , 2166-8
[A case of two re-resections for peritoneal recurrence of pancreatic cancer].
A 63-year-old man underwent subtotal stomach-preserving pancreaticoduodenectomy and intraoperative radiation therapy for pancreatic head cancer (Stage IVa, JPS). Subsequently, he received adjuvant chemotherapy including gemcitabine (GEM). A peritoneal recurrence appeared adjacent to the right colon and the lower pole of the right kidney. He received chemotherapy including S-1 and GEM+S-1. Since the recurrent lesions were localized, he underwent resection for the recurrence lesions 2 years and 9 months after surgery. The resection was R1, and re-recurrence appeared in the lower pole of the right kidney. After chemotherapy and chemoradiotherapy, he underwent re-resection for the recurrence 4 years and 3 months after the first surgery. Three months after re-resection, multiple liver metastases appeared in the bilateral lobes. Reoperation can be one of the multidisciplinary management options for local recurrence of pancreatic cancer under specific conditions.
- 11 July 2008
- Vol. 55, 596-9
Sequential magnetic resonance imaging for evaluation of Kupffer cell function.
Kupffer cells play an important role in liver regeneration and depression of their function is associated with poor outcome. However, there is no clinically safe and reliable method for evaluating Kupffer cell function. We used magnetic resonance imaging following injection of superparamagnetic iron oxide, which is trapped by Kupffer cells, to evaluate Kupffer cell function in 14 patients, including 6 with normal liver and 8 with obstructive jaundice T1-weighed signal intensity of the liver parenchyma was examined every 4 minutes for 60 min after superparamagnetic iron oxide injection. Signal intensity values gradually decreased in both groups after accumulation of iron in the liver. Serum iron levels equally and significantly increased in both groups. In contrast, the values of relative enhancement, percentage of signal intensity of precontrast to postcontrast, between 8-20 minutes after superparamagnetic iron oxide injection were significantly higher in obstructive jaundice group than in the control, indicating Kupffer cell dysfunction in obstructive jaundiced liver. These results indicate that chronological magnetic resonance imaging with superparamagnetic iron oxide is a suitable method for assessment of Kupffer cell function in patients with obstructive jaundice.
- 11 July 2008
- Vol. 55, 596-9
Sequential magnetic resonance imaging for evaluation of Kupffer cell function.
Kupffer cells play an important role in liver regeneration and depression of their function is associated with poor outcome. However, there is no clinically safe and reliable method for evaluating Kupffer cell function. We used magnetic resonance imaging following injection of superparamagnetic iron oxide, which is trapped by Kupffer cells, to evaluate Kupffer cell function in 14 patients, including 6 with normal liver and 8 with obstructive jaundice T1-weighed signal intensity of the liver parenchyma was examined every 4 minutes for 60 min after superparamagnetic iron oxide injection. Signal intensity values gradually decreased in both groups after accumulation of iron in the liver. Serum iron levels equally and significantly increased in both groups. In contrast, the values of relative enhancement, percentage of signal intensity of precontrast to postcontrast, between 8-20 minutes after superparamagnetic iron oxide injection were significantly higher in obstructive jaundice group than in the control, indicating Kupffer cell dysfunction in obstructive jaundiced liver. These results indicate that chronological magnetic resonance imaging with superparamagnetic iron oxide is a suitable method for assessment of Kupffer cell function in patients with obstructive jaundice.
- 31 March 2008
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 43 (3) , 583-585
Congenital esophageal stenosis because of tracheobronchial remnant and treated by circular myectomy: a case report
- 31 March 2008
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 43 (3) , 583-585
Congenital esophageal stenosis because of tracheobronchial remnant and treated by circular myectomy: a case report
- 1 January 2006
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 45 (21) , 1217-1220
A Recovery Case of Acute-Onset Autoimmune Hepatitis Presenting as Fulminant Hepatic Ffailure, Who Received Living Donor-Liver Transplantion
A 23-year-old woman was admitted to our hospital with jaundice and hepatic coma. She had taken a weight-loss supplement for one month before admission. Her clinical and laboratory findings were consistent with fulminant hepatic failure and fulfilled the criteria of autoimmune hepatitis. Despite corticosteroid pulse therapy and plasma exchange, her symptoms and laboratory findings deteriorated. Her condition improved after she received a living donor-liver transplant from her sister. Autoimmune hepatitis usually follows a chronic course, but it should be considered a type of fulminant hepatic failure and treated promptly.
- 1 January 2006
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 45 (21) , 1217-1220
A Recovery Case of Acute-Onset Autoimmune Hepatitis Presenting as Fulminant Hepatic Ffailure, Who Received Living Donor-Liver Transplantion
A 23-year-old woman was admitted to our hospital with jaundice and hepatic coma. She had taken a weight-loss supplement for one month before admission. Her clinical and laboratory findings were consistent with fulminant hepatic failure and fulfilled the criteria of autoimmune hepatitis. Despite corticosteroid pulse therapy and plasma exchange, her symptoms and laboratory findings deteriorated. Her condition improved after she received a living donor-liver transplant from her sister. Autoimmune hepatitis usually follows a chronic course, but it should be considered a type of fulminant hepatic failure and treated promptly.
- Open Access
- 1 September 2000
- Published by SAGE Publications in Cell Transplantation
- Vol. 9 (5) , 693-695
Grafting of Mitomycin C-Treated Islet Xenograft under the Kidney Capsule Produces a Clear Bleb
We have previously shown that mitomycin C (MMC) treatment of donor tissue resulted in significant prolongation of graft survival in allo- and xenotransplantation models. However, the mechanisms involved in this prolongation are not clearly understood. This study aims to shed light on the immune responses to MMC-treated islet xenografting under the kidney capsule. Collagenase-digested WS (RT1k) rat islets incubated for 30 min with MMC and subsequently cultured for 20 h were transplanted into the renal subcapsular space of streptozotocin-induced diabetic C57BL/6 (B6;H-2b) mice. The grafts were harvested on postgrafting day 7 and sections were prepared and stained by hematoxylin and eosin (H&E). Histological study of the grafts in a group not treated with MMC showed marked cellular infiltration and destruction of islet clusters, whereas that of MMC-treated grafts demonstrated a bleb formation under the kidney capsule, in which islet cell clusters were reorganized, creating a layer of cells fixed to the interior of the bleb. Minimal invasion by inflammatory cells was observed only at the edge of the bleb, and most islet cells were protected from these infiltrating cells. In conclusion, MMC treatment induces remodeling of islet structure and forms a bleb under the kidney capsule, where no inflammatory cell infiltration occurs, suggesting that this site is a kind of immunologically privileged environment for xenografted islets.
- 1 September 2000
- Published by SAGE Publications in Cell Transplantation
- Vol. 9 (5) , 693-695
Open AccessGrafting of Mitomycin C-Treated Islet Xenograft under the Kidney Capsule Produces a Clear Bleb
We have previously shown that mitomycin C (MMC) treatment of donor tissue resulted in significant prolongation of graft survival in allo- and xenotransplantation models. However, the mechanisms involved in this prolongation are not clearly understood. This study aims to shed light on the immune responses to MMC-treated islet xenografting under the kidney capsule. Collagenase-digested WS (RT1k) rat islets incubated for 30 min with MMC and subsequently cultured for 20 h were transplanted into the renal subcapsular space of streptozotocin-induced diabetic C57BL/6 (B6;H-2b) mice. The grafts were harvested on postgrafting day 7 and sections were prepared and stained by hematoxylin and eosin (H&E). Histological study of the grafts in a group not treated with MMC showed marked cellular infiltration and destruction of islet clusters, whereas that of MMC-treated grafts demonstrated a bleb formation under the kidney capsule, in which islet cell clusters were reorganized, creating a layer of cells fixed to the interior of the bleb. Minimal invasion by inflammatory cells was observed only at the edge of the bleb, and most islet cells were protected from these infiltrating cells. In conclusion, MMC treatment induces remodeling of islet structure and forms a bleb under the kidney capsule, where no inflammatory cell infiltration occurs, suggesting that this site is a kind of immunologically privileged environment for xenografted islets.
- 15 June 1999
- Published by Wolters Kluwer Health in Transplantation
- Vol. 67 (11) , 1474-1477
PRETREATMENT OF CRUDE PANCREATIC ISLETS WITH MITOMYCIN C PROLONGS GRAFT SURVIVAL TIME IN XENOGENEIC RAT-TO-MOUSE MODEL1
Background. Rejection of pancreatic islet grafts is still a serious problem. We evaluated the effect of mitomycin C (MMC) on the survival of crude islets grafts after xenogeneic islet transplantation. Methods. WS (RT1k) rat islets pretreated with various concentrations of MMC (0, 1, 3.2, 10, 32, 50, 100, 320, and 1,000 μg/ml) were transplanted into C57BL/6 mice with streptozotocin-induced diabetes. In vivo graft function was assessed by a daily measurement of nonfasting blood glucose concentration in each animal. We also examined the separate effect of MMC on purified islets and contaminants present in the crude islet preparation. Results. MMC at doses of 10, 32, 50, and 100 μg/ml resulted in a significant prolongation of the mean graft survival time from a control of 12.4±2.5 days to 23±7.4, 17.5±5.4, 25.5±14.7, and 26.7±8.9 days, respectively. Deterioration of glucose metabolism was noted when the dose exceeded 32 μg/ml, whereas at 320 μg/ml, MMC failed to restore normoglycemia. Prolongation of survival time of crude islets was the result of its effect on islets and contaminant components of the crude islet preparation. In vitro study showed that MMC treatment at a higher concentration than 10 μg/ml reduces the stimulatory as well as proliferative capacity of lymph node cells. Conclusions. Pretreatment of pancreatic islets with MMC at 10 μg/ml prolongs xenograft survival without deterioration of in vivo graft function. This novel treatment modality represents a new strategy for the modulation of immunity of islets and contaminants in crude islet preparations.
- 15 June 1999
- Published by Wolters Kluwer Health in Transplantation
- Vol. 67 (11) , 1474-1477
PRETREATMENT OF CRUDE PANCREATIC ISLETS WITH MITOMYCIN C PROLONGS GRAFT SURVIVAL TIME IN XENOGENEIC RAT-TO-MOUSE MODEL1
Background. Rejection of pancreatic islet grafts is still a serious problem. We evaluated the effect of mitomycin C (MMC) on the survival of crude islets grafts after xenogeneic islet transplantation. Methods. WS (RT1k) rat islets pretreated with various concentrations of MMC (0, 1, 3.2, 10, 32, 50, 100, 320, and 1,000 μg/ml) were transplanted into C57BL/6 mice with streptozotocin-induced diabetes. In vivo graft function was assessed by a daily measurement of nonfasting blood glucose concentration in each animal. We also examined the separate effect of MMC on purified islets and contaminants present in the crude islet preparation. Results. MMC at doses of 10, 32, 50, and 100 μg/ml resulted in a significant prolongation of the mean graft survival time from a control of 12.4±2.5 days to 23±7.4, 17.5±5.4, 25.5±14.7, and 26.7±8.9 days, respectively. Deterioration of glucose metabolism was noted when the dose exceeded 32 μg/ml, whereas at 320 μg/ml, MMC failed to restore normoglycemia. Prolongation of survival time of crude islets was the result of its effect on islets and contaminant components of the crude islet preparation. In vitro study showed that MMC treatment at a higher concentration than 10 μg/ml reduces the stimulatory as well as proliferative capacity of lymph node cells. Conclusions. Pretreatment of pancreatic islets with MMC at 10 μg/ml prolongs xenograft survival without deterioration of in vivo graft function. This novel treatment modality represents a new strategy for the modulation of immunity of islets and contaminants in crude islet preparations.
- Open Access
- 1 January 1999
- Published by Japan Society of Hepatology in Kanzo
- Vol. 40 (4) , 260-263
A Case Of Hyalin Degenerative Mass Lesion Of The Liver.
今回, 我々は術前に肝細胞癌と診断したが, 術後の病理組織学検査では硝子化変性した瘢痕組織を認めるのみであった1例を経験した. 症例は68歳の男性. 60歳時にC型慢性肝炎と診断され, 以後経過観察されていた. 定期検査の腹部超音波および腹部CTで肝S1に2cm大の腫瘤陰影を指摘され, 同部位は腹部MRIではT1強調画像で低信号域, T2強調画像で高信号域として描出された. 腹部血管造影では尾状葉に一致して腫瘍濃染を認めた. 以上の画像検査より肝細胞癌と診断し, 手術を施行したが, 術後の病理組織検査では硝子化変性した瘢痕組織を認めるのみであった. 文献的考察の結果, 現在までにこのような症例の報告はなく, 本例は極めてまれな症例であると考えられた.
- 1 January 1999
- Published by Japan Society of Hepatology in Kanzo
- Vol. 40 (4) , 260-263
Open AccessA Case Of Hyalin Degenerative Mass Lesion Of The Liver.
今回, 我々は術前に肝細胞癌と診断したが, 術後の病理組織学検査では硝子化変性した瘢痕組織を認めるのみであった1例を経験した. 症例は68歳の男性. 60歳時にC型慢性肝炎と診断され, 以後経過観察されていた. 定期検査の腹部超音波および腹部CTで肝S1に2cm大の腫瘤陰影を指摘され, 同部位は腹部MRIではT1強調画像で低信号域, T2強調画像で高信号域として描出された. 腹部血管造影では尾状葉に一致して腫瘍濃染を認めた. 以上の画像検査より肝細胞癌と診断し, 手術を施行したが, 術後の病理組織検査では硝子化変性した瘢痕組織を認めるのみであった. 文献的考察の結果, 現在までにこのような症例の報告はなく, 本例は極めてまれな症例であると考えられた.
- 1 January 1998
- Published by Japan Society of Hepatology in Kanzo
- Vol. 39 (7) , 468-472
A resected case of hepatocelluar carcinoma progressed into the peribiliary capillary plexus(PBCP).
肝細胞癌がperibiliary capillary plexus (PBCP) に発育進展することにより胆管狭窄をきたし, さらには閉塞性黄疸を呈した, 非常にまれな症例を経験したので報告する. 症例は60歳, 男性. 主訴は右季肋部痛及び背部痛. 入院, 精査の結果, 肝細胞癌もしくは胆管細胞癌疑診にて, 当科入院となった. 血液検査では, 肝機能異常とPIVKA-IIの高値を示した. 画像検査において, 肝S4の直径3cmの腫瘍とそれに連続する左胆管内腫瘍栓を認めた. また総胆管には, 約5cmにわたる不整狭窄像を認めた. 以上の検査結果より, 肝細胞癌の胆管内浸潤と診断し, 肝左葉切除術と総胆管切除術を施行した. 摘出標本の病理組織学的検索により, 肝細胞癌のPBCP内に発育進展したための総胆管狭窄と診断された. 文献的考察の結果, 現在までにこのような進展形式をともなう肝細胞癌の報告は検索しえなかった.
- 1 January 1998
- Published by Japan Society of Hepatology in Kanzo
- Vol. 39 (7) , 468-472
A resected case of hepatocelluar carcinoma progressed into the peribiliary capillary plexus(PBCP).
肝細胞癌がperibiliary capillary plexus (PBCP) に発育進展することにより胆管狭窄をきたし, さらには閉塞性黄疸を呈した, 非常にまれな症例を経験したので報告する. 症例は60歳, 男性. 主訴は右季肋部痛及び背部痛. 入院, 精査の結果, 肝細胞癌もしくは胆管細胞癌疑診にて, 当科入院となった. 血液検査では, 肝機能異常とPIVKA-IIの高値を示した. 画像検査において, 肝S4の直径3cmの腫瘍とそれに連続する左胆管内腫瘍栓を認めた. また総胆管には, 約5cmにわたる不整狭窄像を認めた. 以上の検査結果より, 肝細胞癌の胆管内浸潤と診断し, 肝左葉切除術と総胆管切除術を施行した. 摘出標本の病理組織学的検索により, 肝細胞癌のPBCP内に発育進展したための総胆管狭窄と診断された. 文献的考察の結果, 現在までにこのような進展形式をともなう肝細胞癌の報告は検索しえなかった.